Intensity Therapeutics, Inc. (INTS) KPIs and segments

INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$3.28+0.19 (+6.15%)

Close on Nov 11, 2026Market cap $10.71MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Intensity Therapeutics's business

Coming soon

This tab will track the numbers specific to Intensity Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?